Investigation of efficacy and response speed of a combination treatment of escitalopram and repetitive transcranial magnetic stimulation
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2011
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 22 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Sep 2007 The expected completion date for this trial is now 1 Mar 2008.